Home › Compare › BCTXW vs EQR

BCTXW vs EQR: Dividend Comparison 2026

BCTXW yields 222222.22% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BCTXW wins by $1.4076449094288678e+30M in total portfolio value
10 years
BCTXW
BCTXW
● Live price
222222.22%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.4076449094288678e+30M
Annual income
$1,406,399,938,745,922,600,000,000,000,000,000,000.00
Full BCTXW calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — BCTXW vs EQR

📍 BCTXW pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBCTXWEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BCTXW + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BCTXW pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BCTXW
Annual income on $10K today (after 15% tax)
$18,888,889.10/yr
After 10yr DRIP, annual income (after tax)
$1,195,439,947,934,034,100,000,000,000,000,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, BCTXW beats the other by $1,195,439,947,934,034,100,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BCTXW + EQR for your $10,000?

BCTXW: 50%EQR: 50%
100% EQR50/50100% BCTXW
Portfolio after 10yr
$7.038224547144339e+29M
Annual income
$703,199,969,372,961,300,000,000,000,000,000,000.00/yr
Blended yield
99.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

BCTXW
No analyst data
Altman Z
-3.9
Piotroski
2/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BCTXW buys
0
EQR buys
0
No recent congressional trades found for BCTXW or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBCTXWEQR
Forward yield222222.22% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$1.4076449094288678e+30M$47.8K ✓
Annual income after 10y$1,406,399,938,745,922,600,000,000,000,000,000,000.00 ✓$5,475.61
Total dividends collected$1.4075633997820162e+30M$23.0K ✓
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: BCTXW vs EQR ($10,000, DRIP)

YearBCTXW PortfolioBCTXW Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$22,232,922$22,222,222.47$11,380$679.82+$22.22M → BCTXW
2$46,198,083,549$46,174,294,322.26$13,014$837.25+$46198.07M → BCTXW
3$89,718,755,932,306$89,669,323,982,908.17$14,961$1,036.20+$89718755.92M → BCTXW
4$162,845,400,843,462,850$162,749,401,774,615,260.00$17,297$1,289.22+$162845400843.45M → BCTXW
5$276,249,751,218,492,180,000$276,075,506,639,589,670,000.00$20,121$1,613.15+$276249751218492.16M → BCTXW
6$437,989,491,440,595,100,000,000$437,693,904,206,791,440,000,000.00$23,561$2,030.84+$437989491440595136.00M → BCTXW
7$649,026,193,150,457,500,000,000,000$648,557,544,394,616,000,000,000,000.00$27,783$2,573.54+$649026193150457544704.00M → BCTXW
8$898,874,233,030,415,400,000,000,000,000$898,179,775,003,744,500,000,000,000,000.00$33,013$3,284.39+$8.988742330304155e+23M → BCTXW
9$1,163,524,002,752,517,800,000,000,000,000,000$1,162,562,207,323,175,100,000,000,000,000,000.00$39,547$4,223.51+$1.1635240027525178e+27M → BCTXW
10$1,407,644,909,428,867,700,000,000,000,000,000,000$1,406,399,938,745,922,600,000,000,000,000,000,000.00$47,791$5,475.61+$1.4076449094288678e+30M → BCTXW

BCTXW vs EQR: Complete Analysis 2026

BCTXW — Stock

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers. The company has a collaboration with Incyte Corporation to evaluate combination of the Bria-IMT. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.

Full BCTXW Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this BCTXW vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BCTXW vs SCHDBCTXW vs JEPIBCTXW vs OBCTXW vs KOBCTXW vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.